Sep 30, 2025
Inflammatix Announces Three Landmark Publications in Nature Medicine that Redefine Acute Infection and Sepsis Diagnosis and Treatment
Sep 02, 2025
Inflammatix Data in Journal of Clinical Microbiology Validate Accuracy, Robustness, and Ease of Use of TriVerity™ Test System
Jun 10, 2025
Inflammatix Names Martín Vazquez as Chief Operating Officer to Drive National Scale-Up of TriVerity(TM) Test System
Jan 21, 2025
Inflammatix Receives FDA Clearance for First-in-Class TriVerity(TM) Test
Nov 11, 2024
Inflammatix Initiates TriVerity(TM) for Improved Management of Emergency Department Patients with Suspected Infections (TIMED) Trial
Oct 10, 2024
Inflammatix Adds Three MedTech Industry Veterans to Executive Leadership Team
Oct 01, 2024
Inflammatix Presents Data at ACEP24 Showing High Diagnostic and Prognostic Accuracy of its TriVerity(TM) Test Regardless of Patient Immune Status
Mar 04, 2020
New Inflammatix Study in Nature Communications Outlines Breakthrough in Diagnosing Acute Infections by Reading the Immune System
Jan 10, 2020
Inflammatix Announces $32 Million in Series C Funding
Nov 14, 2019
Inflammatix Announces Funding from BARDA to Advance HostDx(TM) Tests
Aug 06, 2019
Inflammatix Wins AACC's Disruptive Technology Award For Its Rapid HostDx(TM) Tests
Oct 04, 2018
Inflammatix to Present New Data at IDWeek 2018 Demonstrating Ability to Perform HostDx(TM) Fever Test to Rapidly Distinguish Bacterial from Viral Infections Across Multiple Laboratory Platforms
Apr 10, 2018
Inflammatix Named a Finalist in Fast Company's 2018 World Changing Ideas Awards for Its Novel HostDx Tests
Feb 15, 2018
New Study Published in 'Nature Communications' Suggests Sepsis Can Be Detected By Measuring the Immune System
Dec 19, 2017
Inflammatix Announces Appointment of Oliver Liesenfeld, M.D., as Chief Medical Officer